|Articles|January 1, 2018
- Pharmaceutical Executive-01-01-2018
- Volume 38
- Issue 1
Pharmaceutical Executive, January 2018 Issue (PDF)
Click the title above to open the Pharmaceutical Executive January 2018 issue in an interactive PDF format.
Advertisement
Articles in this issue
over 8 years ago
Changing Skies: Pharm Exec’s 2018 Industry Forecastover 8 years ago
Q&A: From Gleevec to CAR-Tover 8 years ago
Prices and Competition to Shape the Year Aheadover 8 years ago
CAR-T Concerns for Continued Successover 8 years ago
New Year, Next Steps in Digital Transformationover 8 years ago
Food for Thought in Cancer Fightover 8 years ago
Parting Arrangementsover 8 years ago
Country Report: SwitzerlandAdvertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
The Significance of FDA’s First Warning Letter for Inappropriate Use of AI
2
Jazz Pharmaceuticals to Acquire Actio Biosciences for $1.32 Billion
3
Generating Commercial Evidence from Agentic Field and Brand Engagement to Accelerate Launch Performance
4
M&A Roundup: Novo Nordisk Enters AI Drug Discovery Partnership with Amazon, Innate Pharma Partners with Sobi, Innovent Enters Commercialization Agreement with Daiichi Sankyo
5